p53 isoforms can regulate p53 transcriptional activity

Antibodies, a laboratory manual

(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814

p53 mutant mice that display early ageing-associated phenotypes

Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459

Decision making by p53: life, death and cancer

Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,085

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

DeLeo, A. B., Jay, G. D., Appella, E., DuBois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721

Modulation of mammalian life span by the short isoform of p53

Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586

Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity

Xirodimas, D. P., Saville, M. K., Bourdon, J.-C., Hay, R. T., & Lane, D. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.016 · Cited by 570

On the shoulders of giants: p63, p73 and the rise of p53

Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 496

Drosophila p53 Binds a Damage Response Element at the reaper Locus

Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 474

Mechanisms of p53-mediated intrinsic and extrinsic tumor suppression

Li, H. (2014) · Figshare

Transcriptional regulation of cell life and death decisions by p73

Muppani, N. R. (2013) · Figshare

Studies of mutant p53-targeting small molecules

Zache, N. (2007) · Figshare

Mécanisme de leucémogénèse par les oncogènes SCL et LMO1

Tremblay, M. R. (2009) · doi:10.71781/27559

Upregulation of a spliced variant of human interferon regulatory factor 3 through binding of the transcription factor Sp1 to the promoter

Zhu, L.-H., Qiu, L., Ren, W., & Zhou, G. (2013) · Biomedical Reports · doi:10.3892/br.2013.198

New additions

McCarthy, N. J. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1724

Volume visualization for exploration of population trends in two-dimensional gel electrophoresis protein data

Øye, O. K., Ulvang, D. M., Jørgensen, K. M., Hjelle, S. M., & Gjertsen, B. T. (2012) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2012.6266326

Mecanismos de indução de apoptose pela presença de danos ao DNA: um estudo sobre o papel de p53 na resistência de células de glioma a agentes quimioterápicos.

Batista, L. F. Z. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2008.tde-22092008-170922

Kliniczne znaczenie polimorfizmu Ser326Cys genu hOGG1 u chorych na niedrobnokomórkowego raka płuca (NDRP)

Drozdowska, A. (2008)

The p53 homolog p63 modulates acute and chronic damage in irradiated salivary glands

Mitchell, G. C. (2010) · UA Campus Repository (The University of Arizona)

Pharmacological targeting of mutant p53 family members

Rökaeus, N. (2011) · Figshare

Molecular Genetic Study of the Allelic State of the Cell Cycle Genes (TP53, BRCA1) and Features of the Regulation of the Cytokine Cascade in Breast Cancer

Gantsev, S. K., Gorbunova, V. Y., Галикеева, Г. Ф., Vorobyeva, E. V., Vasilyeva, E. M., & Rustamkhanov, R. A. (2013) · Journal of cancer research updates · doi:10.6000/1929-2279.2013.02.03.6

Análise de polimorfismos da família p53 e sua via regulatória como fatores de risco para aneuploidia

Boquett, J. A. (2013) · Americanae (AECID Library)

Protein interactions with drosophila p53

Cajee, U.-F. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)

Étude de l’activité des présumés IRES de l’ARN messager de p53

Cadar, A. E. (2014) · doi:10.71781/31878

Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression

Selivanova, G., Höglund, P., Piaggio, G., Elena, R., Pereira, T., Wright, A. R., Wadelius, C., & Universitit, U. (2014)

INTEGRACIÓN DE LA FUNCIÓN DE VRK2 EN LAS RUTAS DE SEÑALIZACIÓN DE JNK Y P53.

Blanco, S. (2006) · DIGITAL.CSIC (Spanish National Research Council (CSIC))

The role of hnRNP A1 and hnRNP C1/C2 in the regulation of the stress responsive genes Cyp2a5/2A6 and p53.

Christian, K. J. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Longevity Assurance by Genome Maintenance

Hasty, P., Suh, Y., & Vijg, J. (2013) · CRC Press eBooks · doi:10.1201/b14587-3

Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins

(2016) · Frontiers research topics · doi:10.3389/978-2-88919-961-7

Molecular Pathology of Lung Tumors

Popper, H. (2016) · Springer eBooks · doi:10.1007/978-3-662-50491-8_19

Δ133p53 Functions to Maintain Redox Homeostasis in Response to Low ROS Stresses

Chen, J. J. (2016) · Single Cell Biology · doi:10.4172/2168-9431.1000154

The Role of Alternative Splicing During the Cell Cycle and Programmed Cell Death

Xialu Li, C., & Manley, J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00280-1

The p53 family interacting pathways in carcinogenesis and cellular response to DNA damage

Johnson, J. L. (2007) · doi:10.6083/m42f7kd0

Regulation of the transcription factor p63 by [beta]TrCP

Gallegos, J. R. (2008) · doi:10.6083/m4513w4d

Role of TAp73 in the Transformation of Mouse Ovarian Surface Epithelium

Khan, F. (2011) · TSpace (University of Toronto)

Supplemental Figure Legends

Satler, J. D., Carstens, B. C., & Hedin, M. C. (2015) · DRYAD · doi:10.5061/dryad.68s40.2/3.2

Towards the Investigation of the Effects of Nitration on the Activity of the Human p53 Tumour Suppressor Protein. Nitration of the p53 Tumour Suppressor Protein

Husaini, R. (2014) · Bradford Scholars (University of Bradford)

Making sense from nonsense and missense : pharmacological rescue of mutant tumor suppressor p53

Zhang, M. (2018) · Figshare

TP53 somatic mutations are associated with somatic mitogenome substitutions but not indels in colorectal cancer cells

Skonieczna, K., Jawień, A., Marszałek, A., & Grzybowski, T. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3063

Contrôle physiologique et pharmacologique de la biosynthèse des leucotriènes

Boudreau, L. H. (2012) · Corpus Université Laval (Université Laval)

P53 Expression In Colorectal Epithelial Neoplasms And Its Relation To Clinical And Histopathological Features

Zgurova, N., & Tzaneva, M. A. (2018) · Varna Medical Forum · doi:10.14748/vmf.v7i2.5624

The role of p53 family members in myogenic differentiation and rhabdomyosarcoma development

Çam, H. (2006) · Online Publication Service of Würzburg University (Würzburg University)

Loss of Nance-Horan Syndrome b ( nhsb ) prevents expansion growth of retinal progenitor cells by selective up-regulation of Δ113p53Preprint

Vorster, P. J., Ojumu, J., DICKINSON, A. J. G., & Walsh, G. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/775171

p63 and potential p63 targets in squamous cell carcinoma of the head and neck

Boldrup, L. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Role of P73 and P53 in the biology of neural stem cells and in the architecture of the neurogenic niches in mouse brain = Función de P73 y P53 en la biología de las células troncales neuronales y en la arquitectura de los nichos neurogénicos en cerebro de ratón

González-Cano, L. (2012) · doi:10.18002/10612/2888

Discovery and characterization of a novel splice variant of the p53 tumor suppressor gene in a human T cell leukemia cellline.

Li, X., Lei, Y., Yu, Y. Y., Zhang, Y., Zhang, W., Shen, H., Tao, C., Wu, F., Huang, S., & Shao, H. (2020) · PubMed

Porcine model elucidates function of p53 isoform in carcinogenesisPreprint

Niu, G., Hellmuth, I., Flisikowska, T., Pausch, H., Rieblinger, B., Carrapeiro, A. R., Schade, B., Böhm, B., Kappe, E., Fischer, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.07.286005

Transcriptomic Signature of Radiation Response in Li-Fraumeni Syndrome

Sauberli-Stewart, K. (2019) · TSpace (University of Toronto)

Faculty Opinions recommendation of p53 activation by knockdown technologies.

Prince, V. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1090492.543763

Structural-Functional Diversity of p53 Proteoforms

Naryzhny, S., & Legina, O. (2019) · Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry · doi:10.1134/s199075081904005x · Cited by 2

Regulation of the p53 Tumor‐Suppressor Protein by Ubiquitin and Ubiquitin‐Like Molecules

Xirodimas, D. P. (2007) · Wiley eBooks · doi:10.1002/9783527620234.ch2

Übersicht über die klinischen Merkmale des Li-Fraumeni Syndroms und die aktuelle europäische Leitlinie des ERN GENTURIS

Kratz, C. P., Steinke‐Lange, V., Spier, I., Aretz, S., Schröck, E., & Holinski‐Feder, E. (2023) · TumorDiagnostik & Therapie · doi:10.1055/a-2013-9113

p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities

Giono, L. E., Ladelfa, M. F., & Monte, M. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_4

Data from Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation

Jordan, J. J., Inga, A., Conway, K., Edmiston, S. N., Carey, L., Wu, L., & Resnick, M. A. (2023) · doi:10.1158/1541-7786.c.6542128

Data from Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation

Jordan, J. J., Inga, A., Conway, K., Edmiston, S. N., Carey, L., Wu, L., & Resnick, M. A. (2023) · doi:10.1158/1541-7786.c.6542128.v1

Data from p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities

Tong, D. R., Zhou, W., Katz, C., Regunath, K., Venkatesh, D., Ihuegbu, C., Manfredi, J. J., Laptenko, O., & Prives, C. L. (2023) · doi:10.1158/1541-7786.c.6545187.v1

FUSE binding protein1 interacts with Tumor Suppressor p53 and p53-Isoforms through their DNA Binding domain: Mapping the FBP1 binding sitePreprint

Dixit, U., Pandey, V., Comollo, T. W., Upadhyay, A. K., & Pandey, V. N. (2023) · Research Square · doi:10.21203/rs.3.rs-3299317/v1

Molecular genetics of soft tissue tumors

Lasota, J. P. (2016) · Cambridge University Press eBooks · doi:10.1017/9781107707504.006

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomasPreprint

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.13.562180

FUSE binding protein1 interacts with Tumor Suppressor p53 and p53-Isoforms through their DNA Binding domain: Mapping the FBP1 binding site

Dixit, U., Pandey, V., Comollo, T. W., Upadhyay, A. K., & Pandey, V. N. (2023) · Indian Journal of Biochemistry and Biophysics · doi:10.56042/ijbb.v60i11.5393

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomasPreprint

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Vaysse-Zinkhöfer, W., Eldawra, E., Rakotopare, J., et al. (2024) · eLife · doi:10.7554/elife.92774.1

Bioinformatics and Genetic Correlation Studies of Functional Gene Partners of Tp53 Gene Associated With Hepatocellular Carcinoma and Liver Cirrhosis Among Patients in Ucth, CalabarPreprint

Ubi, G. M., Ekpenyong, B. B., Edodi, I. O., Effiom, B. E., Etangetuk, N. A., Ettah, I. A., Edu, N. E., Kooffreh, M. E., Osondu, C. A., & Essien, I. S. (2024) · Research Square · doi:10.21203/rs.3.rs-4530115/v1

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomasPreprint

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., et al. (2024) · eLife · doi:10.7554/elife.92774.2

A mathematical treatment of the impact of p53 signalling on the expression of the transcription factor E2F in the CycE/Cdk2 subsystem in cancerous cells

Qwabe, N., & Govinder, K. S. (2024) · Physica D Nonlinear Phenomena · doi:10.1016/j.physd.2024.134348

p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners

Brdar, A., Osterburg, C., Münick, P., Machel, A. C., Rathore, R., Osterburg, S., Yüksel, B., Schäfer, B., Desch, K., Langer, J. D., et al. (2025) · eLife · doi:10.7554/elife.103537.3

p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partnersPreprint

Brdar, A., Osterburg, C., Münick, P., Machel, A. C., Rathore, R., Osterburg, S., Yüksel, B., Schäfer, B., Desch, K., Langer, J. D., et al. (2024) · eLife · doi:10.7554/elife.103537.1

Computational insights into Sitahe (Leuconotis eugenifolia) bioactive compounds: A promising approach for radioprotection through p53 inhibition

Perkasa, D. P., Kurnia, I., Fakih, T. M., Kisnanto, T., Ramadhani, D., Surniyantoro, H. N. E., Tuasikal, B. J., Forentin, ⁠. M., & Syaifudin, M. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e139559

Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregationPreprint

Zhao, L., Punga, T., & Sanyal, S. (2025) · eLife · doi:10.7554/elife.106469.1

p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partnersPreprint

Brdar, A., Osterburg, C., Münick, P., Machel, A. C., Rathore, R., Osterburg, S., Yüksel, B., Schäfer, B., Desch, K., Langer, J. D., et al. (2025) · eLife · doi:10.7554/elife.103537.2

Specificity of Aberrant Exons in a Saturated Background of Differentially Expressed ExonsPreprint

Das, U., Nguyen, H. D., Yang, J., Ogunsola, S. S., Hamilton, M., Wu, Y., Liu, L., Cao, W., Liu, C., & Xie, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.25.661610

Decoding the Transcriptional Complexity of the Human BRCA2 DNA Repair Gene Using Hybrid-seq

Adamopoulos, P. G., Boti, M. A., Athanasopoulou, K., Tsiakanikas, P., Daneva, G. N., & Scorilas, A. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11180-6

Theranostics in gastric and colorectal cancer

Basak, S., Chakrabarty, S., Bhattacharya, J., Dutta, K., Dhar, A. K., & Palei, N. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34199-1.00009-0

Molecular Pathology of Lung Tumors

Popper, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-91697-7_19

p63 in Squamous Differentiation and Cancer

Roop, D. R., & Koster, M. I. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7203-3_12

Studies of p63 and p63 related proteins in patients diagnosed with oral lichen planus

Ebrahimi, M. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · doi:10.13140/rg.2.2.13240.44800

Sentinel Gene Within Cell Territory and Molecular Platforms in Cancer: Methylation Diversity of p53 Gene in Brain Tumors

Mehdipour, P., & Karami, F. (2015) · Springer eBooks · doi:10.1007/978-94-017-9639-2_8

p63 – from expression to function : studies of normal oral mucosa and squamous cell carcinoma of the head and neck

Thurfjell, N. (2007) · DiVA at Umeå University (Umeå University)

Additional file 1 of P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788590

Additional file 2 of P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788593

Additional file 4 of P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788602

Additional file 3 of P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788596

Additional file 1 of Sensitivity to tumor development by TALEN-mediated Trp53 mutant genes in the susceptible FVB/N mice and the resistance C57BL/6 mice

Yun, W. B., Kim, J. E., Lee, M. L., Choi, J. Y., Park, J. J., Song, B. R., Kang, B. C., Nam, K. T., Lee, H.-W., & Hwang, D. Y. (2021) · Figshare · doi:10.6084/m9.figshare.17089606

First functional evidence that a rare germline TP53β variant drives senescence-associated immune suppression and impairs apoptosis and cell migration in breast cancer patients

Christowitz, C., Olivier, D. W., van der Merwe, N., Kotze, M. J., & Engelbrecht, A. (2026) · Translational Oncology · doi:10.1016/j.tranon.2025.102616

Structural potential of the 5′ noncoding regions of the mRNAs encoding p53 isoforms

Dutkiewicz, M., & Żydowicz-Machtel, P. (2026) · Acta Biochimica Polonica · doi:10.3389/abp.2026.15861

Disruption of the ∆40p53/ miR ‐4671‐5p/ SGSH axis results in intra‐S‐phase arrest and poor cancer prognosis

Pal, A., Ghosh, P. K., Ghosh, S., Tripathi, S. K., Patra, S., Khan, D., Maitra, A., & Das, S. (2026) · FEBS Journal · doi:10.1111/febs.70465

Etude des cellules souches et progénitrices mammaires et de leur contribution à la tumorigenèse : rôle des facteurs de transcription Myc et p53

Chiche, A. (2012) · doi:10.70675/67609440zb6dez49d8z872az1256bad88650

Etude de la fonction de HIPK1, sa régulation et son implication en oncologie

Rey, C. (2010) · theses.fr (ABES) · doi:10.70675/4d830220z8b4dz449fzac53zd4e99eac2d5b

N-terminal isoforms of the p53 tumour suppressor protein : effects on p53 transcriptional activity and expression in cutaneous melanoma

Hafsi, H. (2012) · theses.fr (ABES) · doi:10.70675/636eb035zeb70z452ez8b98z0fdc80a752bb

Expression et fonctions biologiques de l’isoforme ΔNp63

de Gasperis, A. (2011) · theses.fr (ABES) · doi:10.70675/3b754ccbz3f14z4949z9f45z1bdd5995d3d3

The role of NEDD8 pathway in cell invasion and strategies for the use of NEDD8 inhibitors in the clinic

Malhab, L. J. B. (2016) · theses.fr (ABES) · doi:10.70675/a9a79207z0857z4ed5zb207z749cdceb9430

Caractérisation de l'axe intégrine α5β1/protéine p53 dans les gliobastomes humains : application à une thérapie ciblée anti-tumorale

Renner, G. (2016) · theses.fr (ABES) · doi:10.70675/deb4fa44ze885z42b5zbaf7zdb798d1b1b3a

Host-pathogens interactions during RSV / S. pneumoniae infection immune response and p53 pathway

Machado, D. B. B. (2017) · theses.fr (ABES) · doi:10.70675/3b4a9038z62abz41fcz8fa8zd0dbd4dcbfe4

Étude de l'infection par le métapneumovirus humain : facteurs de virulence et développement de vaccins vivants atténués

Dubois, J. (2018) · theses.fr (ABES) · doi:10.70675/464d733fz50f4z4336zab91z19d0652faf12

The regulation of the p53 isoform p47 following Endoplasmic Reticulum (ER) stress, and physiological implication of single cancer-derived synonymous mutations in initiation of p53 mRNA translation

Fusée, L. T. S. (2020) · theses.fr (ABES) · doi:10.70675/7d11d779zac70z4ae9zba4bzd0c51b4ce40b

Identification des gènes impliqués dans la coopération oncogénique avec BCR-ABL1 dans la Leucémie Myéloïde Chronique

Rousseau, E. (2018) · theses.fr (ABES) · doi:10.70675/8db48039z20f0z44afz9da8z512610658f1e

Développement d'un biosenseur fluorescent d'un mutant de p53 sujet à l'agrégation dans les cancers

Pellerano, M. (2019) · theses.fr (ABES) · doi:10.70675/f84edc5bz284az4a6cz9cf3z934f0180c259

Regulation of Netrin-1 by p53 isoforms

Sun, Y. (2020) · theses.fr (ABES) · doi:10.70675/814a2023zacd3z4475z897dz6ee94580c5a3

The role of p53 during chikungunya virus infection in mammal and insect

Cappuccio, L. (2020) · theses.fr (ABES) · doi:10.70675/1193d94cz9984z4118z9b28z95b7df7d5f00

Rôles et régulation des isoformes protéiques d'HBZ du HTLV-1 & de Fra-2 dans la Leucémie T de l'Adulte

Tram, J. (2022) · theses.fr (ABES) · doi:10.70675/1ae465a5zeef2z4046za34cz561b7f0bf021

Conséquences pathologiques des dérégulations de la voie p53-DREAM : insuffisance médullaire, microcéphalie et cancer

Rakotopare, J. (2024) · theses.fr (ABES) · doi:10.70675/cc79cc10zbaf8z4e88za003z8a8d37707576

Syndrοme de Li-Fraumeni : apprοches fοnctiοnnelles visant à appréhender la variabilité génοtypique et phénοtypique

Louis, J. (2025) · theses.fr (ABES) · doi:10.70675/3c8e180cz8248z44f3z9e6ezc2ee07754697

Natural Modulators of the TP53 Pathway: Potential Herbal and Plant‐Derived Agents for Cancer Therapy

Nandi, S., Naskar, A., Khatua, S., Acharya, K., Büsselberg, D., Herrera‐Bravo, J., Arancibia‐Díaz, A., Setzer, W. N., Rotariu, L. S., Dragunescu, A. A., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70323

A mathematical perspective into the p53 protein on the expression of the transcription factor E2F in CycD/Cdk4(6) subsystem

Qwabe, N., & Govinder, K. (2026) · Afrika Matematika · doi:10.1007/s13370-026-01450-w

The p53 Isoforms as Potential Biomarkers in Different Cancer Entities

pavic, C. S., Horvat, A., Tadijan, A., Josić, J., Deželjin, M., Jembrek, M. J., Vlašić, I., & Slade, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125153

Primer-walking sequencing identifies predominantly noncoding TP53 variants in canine cancers

Mathiyalagan, R., Lee, C., Jo, Y., Lee, J., & Song, J. (2026) · Journal of Veterinary Science · doi:10.4142/jvs.25325

Molecular Perspective on Pancreatic Cancers with a Focus on Genetics, Genomics, and Diagnostics

Kaya, Ş., ÖZTÜRK, M. M., Ateşşahin, D. A., BARAL, İ., & Daştan, S. D. (2026) · Cumhuriyet Science Journal · doi:10.17776/csj.1854954

A hybrid deep learning framework for WT or mutant peptide prediction using p53 mutation data

Patil, M. R., & Bihari, A. (2026) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/sagmb-2025-0078

TP53 mutations predict poor breast cancer–specific survival in ER-positive breast cancer patients

Ragnarsdóttir, S., Frick, E. A., Stefansson, O. A., Guðjόnsson, Þ., Tryggvadóttír, L., Aspelund, T., Bjarnadóttir, O., Vidarsdóttir, L., & Sigurdsson, S. (2026) · Cancer Epidemiology · doi:10.1016/j.canep.2026.103204

Switches in alternatively spliced isoforms impact protein and drug interactions in melanoma, ovarian cancer, and acute myeloid leukemia

Karakulak, T., Aebersold, R. H., Ak, M., Alquaddoomi, F., Albert, S. I., Albinus, J. B., Alborelli, I., Andani, S., Attinger, P.-O., Bacac, M., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03638-0

The Isoforms of the p53 Protein

Khoury, M. P., & Bourdon, J.-C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000927 · Cited by 191

p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?

Bartolomei, L., Pretto, B., Brugnara, S., Sontacchi, A., Dassi, V., Bousrih, A., Damaggio, C., Flangini, F., Bisio, A., & Ciribilli, Y. (2026) · Cancers · doi:10.3390/cancers18071057 · Cited by 3

P53 and cancer

Das, D. (2011)

p53: link to the past, bridge to the futurePreprint

Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.1362905 · Cited by 81

p53 Family Isoforms

Bourdon, J. (2007) · Current Pharmaceutical Biotechnology · doi:10.2174/138920107783018444 · Cited by 81